isoproterenol has been researched along with scutellarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, L; Chen, X; Huang, W; Zhang, H; Zheng, G; Zhou, H; Zhou, X | 1 |
| Fang, S; Jing, J; Li, L; Li, R; Liu, W; Lu, Y; Wang, C; Yang, C; Yang, S | 1 |
2 other study(ies) available for isoproterenol and scutellarin
| Article | Year |
|---|---|
Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats.
Topics: Actins; Animals; Apigenin; Basic Helix-Loop-Helix Transcription Factors; Calcium-Binding Proteins; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Glucuronates; Heart; Homeodomain Proteins; Intercellular Signaling Peptides and Proteins; Isoproterenol; Jagged-1 Protein; Male; Membrane Proteins; Molecular Structure; Myocardium; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Receptor, Notch1; Serrate-Jagged Proteins; Transcription Factor HES-1; Ventricular Function | 2014 |
PLGA nanoparticles enhanced cardio-protection of scutellarin and paeoniflorin against isoproterenol-induced myocardial ischemia in rats.
Topics: Animals; Coronary Artery Disease; Isoproterenol; Male; Myocardial Ischemia; Nanoparticles; Rats; Rats, Sprague-Dawley | 2023 |